Page last updated: 2024-09-04

tx 3301 and aspirin

tx 3301 has been researched along with aspirin in 61 studies

Compound Research Comparison

Studies
(tx 3301)
Trials
(tx 3301)
Recent Studies (post-2010)
(tx 3301)
Studies
(aspirin)
Trials
(aspirin)
Recent Studies (post-2010) (aspirin)
69151648,9476,81713,778

Protein Interaction Comparison

ProteinTaxonomytx 3301 (IC50)aspirin (IC50)
Prostaglandin G/H synthase 1 Bos taurus (cattle)0.35
Integrin beta-3Homo sapiens (human)5
Prostaglandin G/H synthase 1Ovis aries (sheep)0.8252
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)1.375
Integrin alpha-IIbHomo sapiens (human)5
Prostaglandin G/H synthase 1Homo sapiens (human)2.271
Substance-P receptorCavia porcellus (domestic guinea pig)2.4
Prostaglandin G/H synthase 2Homo sapiens (human)2.15
Urotensin-2 receptorRattus norvegicus (Norway rat)0.3
4-aminobutyrate aminotransferase, mitochondrialRattus norvegicus (Norway rat)2.4
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.35
Prostaglandin G/H synthase 2Ovis aries (sheep)2.4081

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.64)18.7374
1990's1 (1.64)18.2507
2000's43 (70.49)29.6817
2010's15 (24.59)24.3611
2020's1 (1.64)2.80

Authors

AuthorsStudies
Maurer, HJ1
Annemans, L; Dresse, A; Kurz, X1
Cohen, SN1
Bergmann, SR2
Hilleman, DE; Lenz, TL1
Scheen, AJ1
Kipp, A1
Hansen, DB1
Anderson, JD; Littmann, L; Monroe, MH1
Malinin, AI; Sane, DC; Serebruany, VL1
Lenz, T; Wilson, A1
Haberl, R1
Redman, AR; Ryan, GJ1
Fisher, M; Moonis, M1
Atar, D; Ferguson, JJ; Hanley, DF; Serebruany, VL1
Marissal, JP; Selke, B1
Lindberg, M1
Atar, D; Hennekens, CH; Jilma, B; Malinin, AI; Sane, DC; Serebruany, VL; Takserman, A1
Gray, CS; Morton, JA; Newton, J1
Beck, GJ; Dember, LM; Depner, TA; Dixon, BS; Feldman, HI; Gassman, JJ; Greene, T; Himmelfarb, J; Hunsicker, LG; Kaufman, JS; Lawson, JH; Meyers, CM; Middleton, JP; Radeva, M; Schwab, SJ; Whiting, JF1
Schuler, G1
Horton, HL1
Byrne, MF; Conroy, R; Cox, D; Dooley, M; Fitzgerald, DJ; Maree, AO1
Ackerstaff, RG; de Borst, GJ; de Vries, JP; Hilgevoord, AA; Moll, FL; van de Pavoordt, HD; van der Mee, M1
Macdonald, S1
Sedrakyan, A; Shih, C1
Hanley, DF; Malinin, AI; Serebruany, VL1
Hanley, DF; Malinin, AI; Pokov, AN; Serebruany, VL1
Diener, HC; Sacco, R; Yusuf, S1
Hoover, PL; Mold, JW1
Barabás, JB; Horváth, C; Joób-Fancsaly, A; Kalmár, G; Koppány, F1
Jao, T; Jeng, JS; Tsai, TH1
Brahin, E; Dessain, S; Ezekowitz, MD; Gracely, E; Nagarakanti, R; Notaro, LA; Usman, MH1
Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V1
Schwab, S1
Meyer, D1
Dengler, R; Diener, HC; Eschenfelder, CC; Grond, M; Haberl, R; Kastrup, A; Leonard, J; Machnig, T; Schumacher, H; Schwartz, A; Weissenborn, K1
Crown, N; Mysak, T1
Bédard, M; Dubois, S; Gibbons, C; Hargadon, J; Joy, K1
Eisert, C; Fong, A; Hanley, D; Sani, Y; Schevchuck, A; Serebruany, V1
Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kusek, JW; Lawson, JH; Radeva, MK; Vazquez, MA1
Horie, Y; Ikeda, Y; Uchiyama, S; Urano, Y; Yamaguchi, T1
Bath, P; Hogg, C; Pocock, S; Tracy, M1
Collins, R; Coughlan, T; Cox, D; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tobin, WO1
Brickl, R; Ehrlich, J; Eisert, W; Offman, E; Schobelock, MJ; VanderMaelen, CP1
Bath, PM; Cotton, D; Diener, HC; Sacco, RL; Sha, N; Weber, R; Weimar, C1
Alasty, P; Hamishehkar, H; Monajjemzadeh, F; Valizadeh, H1
Abbott, KC; Himmelfarb, J; Little, DJ; Lowe, SR; Nee, R; Parker, AL; Yuan, CM1
Asher, CR; Buitrago, I; Wolinsky, D1
Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P1
Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW1
Bdiiwi, S; Boison, D; Boktor, H; Castro, D; Dadario, NB; Finkle, D; Greenberg, P; Khandelwal, P; Koziol, J; Kyi, HH; Libutti, SK; Liu, J; Ly, K; Malhotra, R; Maninderpal, K; Nanda, A; Nipun, S; Patel, S; Patrawalla, A; Singla, A; Sonig, A; Subanna, S; Sutherland, A; Xie, Y; Yan, R1

Reviews

9 review(s) available for tx 3301 and aspirin

ArticleYear
Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke

2000
[Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
    Revue medicale de Liege, 2000, Volume: 55, Issue:10

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Primary Prevention; Stroke; Treatment Outcome

2000
Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
    Clinical pharmacokinetics, 2003, Volume: 42, Issue:10

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine

2003
Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:1

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Stroke; Ticlopidine

2004
Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:4

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine

2003
[Current issues of anticoagulation therapy in the course of dental treatment and oral surgery].
    Fogorvosi szemle, 2008, Volume: 101, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dental Care; Dipyridamole; Drug Administration Schedule; Drug Combinations; Humans; Oral Surgical Procedures; Platelet Aggregation Inhibitors; Ticlopidine

2008
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8

    Topics: Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome

2009
Antiplatelets and stroke outcomes: state of the science.
    Critical care nursing clinics of North America, 2009, Volume: 21, Issue:4

    Topics: Arachidonic Acid; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Combinations; Evidence-Based Practice; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Safety; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome

2009
Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, May-01, Volume: 67, Issue:9

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Meta-Analysis as Topic; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke

2010

Trials

15 trial(s) available for tx 3301 and aspirin

ArticleYear
Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    American journal of hematology, 2003, Volume: 72, Issue:4

    Topics: Adenosine Diphosphate; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Capsules; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Stroke; Time Factors

2003
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    European journal of pharmacology, 2004, Sep-24, Volume: 499, Issue:3

    Topics: Aged; Antigens, CD; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; CD40 Ligand; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Function Tests; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 24; Time Factors; Treatment Outcome

2004
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
    Stroke, 2006, Volume: 37, Issue:8

    Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Humans; Logistic Models; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane B2; Treatment Outcome

2006
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:2

    Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial

2007
Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:1

    Topics: Adult; Antigens, CD; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Biomarkers; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Membrane Glycoproteins; Reference Values; Research Design; Time Factors

2008
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-b
    Clinical therapeutics, 2008, Volume: 30, Issue:2

    Topics: Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Biomarkers; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome

2008
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:3

    Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Erythrocytes; Female; Humans; Ischemia; Leukocytes; Male; Middle Aged; Risk Factors; Spectrometry, Fluorescence; Stroke; Time Factors; Treatment Outcome

2009
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    The Lancet. Neurology, 2010, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Germany; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Time Factors

2010
Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:1

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Atherosclerosis; Biomarkers; Case-Control Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Pharmacokinetics; Platelet Aggregation Inhibitors; Stroke

2011
Use of aspirin associates with longer primary patency of hemodialysis grafts.
    Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:4

    Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Chronic Disease; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Thrombosis; Treatment Outcome; Vascular Patency

2011
The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.
    Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 31, Issue:6

    Topics: Aged; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Treatment Outcome

2011
Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2013, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Cross-Over Studies; Dipyridamole; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Young Adult

2013
Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.
    Cerebrovascular diseases (Basel, Switzerland), 2013, Volume: 35, Issue:6

    Topics: Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome

2013
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft.
    Clinical nephrology, 2014, Volume: 81, Issue:1

    Topics: Adult; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Cost-Benefit Analysis; Dipyridamole; Double-Blind Method; Drug Combinations; Graft Occlusion, Vascular; Humans; Monte Carlo Method; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Renal Dialysis

2014
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection.
    PloS one, 2023, Volume: 18, Issue:1

    Topics: Antiviral Agents; Aspirin; Aspirin, Dipyridamole Drug Combination; COVID-19; Female; Humans; SARS-CoV-2; Treatment Outcome

2023

Other Studies

37 other study(ies) available for tx 3301 and aspirin

ArticleYear
[Coagulation disorder following angiography with a nonionic tri-iodized contrast medium? Effect due to contrast medium or to heparin?].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1985, Volume: 143, Issue:6

    Topics: Aortography; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Coagulation Disorders; Blood Coagulation Tests; Contrast Media; Dipyridamole; Drug Combinations; Heparin; Humans; Iopamidol; Iothalamic Acid; Male; Middle Aged

1985
[An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)].
    Revue medicale de Liege, 1998, Volume: 53, Issue:5

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Belgium; Cerebrovascular Disorders; Cost-Benefit Analysis; Costs and Cost Analysis; Delayed-Action Preparations; Dipyridamole; Disease-Free Survival; Drug Combinations; Drug Costs; Economics, Pharmaceutical; Follow-Up Studies; Humans; Markov Chains; Placebos; Platelet Aggregation Inhibitors; Recurrence; Sensitivity and Specificity; Social Security

1998
Aggrenox: a combination of antiplatelet drugs for stroke prevention.
    The Medical letter on drugs and therapeutics, 2000, Feb-07, Volume: 42, Issue:1071

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fees, Pharmaceutical; Humans; Platelet Aggregation Inhibitors; Stroke

2000
Dipyridamole plus aspirin in cerebrovascular disease.
    Archives of neurology, 2000, Volume: 57, Issue:7

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Research Design; Risk Assessment; Scientific Misconduct; Stroke; Treatment Outcome

2000
Alert to physicians: possible interaction of aggrenox and adenosine.
    Journal of the American College of Cardiology, 2000, Volume: 36, Issue:4

    Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents

2000
Aggrenox and stress testing.
    Circulation, 2001, Feb-27, Volume: 103, Issue:8

    Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemia; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents

2001
Second stroke.
    Journal of dental hygiene : JDH, 2000,Spring, Volume: 74, Issue:2

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Chemoprevention; Dipyridamole; Drug Approval; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke; United States; United States Food and Drug Administration

2000
Antithrombotic drugs for secondary stroke prophylaxis--a comment.
    Pharmacotherapy, 2001, Volume: 21, Issue:8

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine

2001
Adenosine and Aggrenox: a hazardous combination.
    Annals of internal medicine, 2002, Jul-02, Volume: 137, Issue:1

    Topics: Adenosine; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Bradycardia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Female; Heart; Humans; Radionuclide Imaging

2002
[Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschritte der Medizin, 2002, May-09, Volume: 144, Issue:19

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Treatment Outcome

2002
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
    MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30

    Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine

2003
[PRoFESS study presented. Change in secondary prevention].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors

2003
[ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke

2003
[Secondary prevention after stroke. Doubled performs better].
    MMW Fortschritte der Medizin, 2003, Nov-13, Volume: 145, Issue:46

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Placebos; Platelet Aggregation Inhibitors; Stroke

2003
[After stroke or TIA. Double protection by second platelet inhibitor].
    MMW Fortschritte der Medizin, 2003, Dec-11, Volume: 145, Issue:50

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Placebos; Practice Guidelines as Topic; Risk; Stroke

2003
Noncompliance in antiplatelet trials: the AGATE trial perspective.
    Stroke, 2004, Volume: 35, Issue:6

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Refusal

2004
Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France.
    PharmacoEconomics, 2004, Volume: 22, Issue:10

    Topics: Adolescent; Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Confidence Intervals; Cost-Benefit Analysis; Dipyridamole; Double-Blind Method; Drug Combinations; Female; France; Humans; Male; Middle Aged; Monte Carlo Method; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke

2004
[Asasantin Retard or Persantin Retard+ASA?].
    Ugeskrift for laeger, 2004, Jun-07, Volume: 166, Issue:24

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stroke

2004
[ASS plus dipyridamole instead of ASS monotherapy. Risk for second stroke cut in half].
    MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention

2004
Counting the true cost of antiplatelet therapy for stroke prevention.
    Age and ageing, 2005, Volume: 34, Issue:3

    Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; United Kingdom

2005
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
    Clinical trials (London, England), 2005, Volume: 2, Issue:5

    Topics: Algorithms; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Sample Size; Vascular Patency

2005
[Germany's girths in an international comparison].
    Krankenpflege Journal, 2005, Volume: 43, Issue:7-10

    Topics: Abdominal Fat; Adult; Anthropometry; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Mass Index; Cardiovascular Diseases; Cerebral Infarction; Combined Modality Therapy; Cross-Cultural Comparison; Dipyridamole; Drug Combinations; Female; Germany; Humans; Male; Practice Guidelines as Topic; Secondary Prevention; United Kingdom

2005
[New DGN-/DSG guidelines].
    Krankenpflege Journal, 2005, Volume: 43, Issue:7-10

    Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Cross-Cultural Comparison; Dipyridamole; Drug Combinations; Germany; Humans; Ischemic Attack, Transient; Practice Guidelines as Topic; Societies, Medical; United Kingdom

2005
Secondary stroke prevention and antiplatelet therapy.
    Journal of the American College of Cardiology, 2006, Jun-20, Volume: 47, Issue:12

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke

2006
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007, Volume: 34, Issue:2

    Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Randomized Controlled Trials as Topic; Research Design; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial

2007
Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals.
    Medical care, 2007, Volume: 45, Issue:10 Supl 2

    Topics: Antipsychotic Agents; Appetite Depressants; Aspirin; Aspirin, Dipyridamole Drug Combination; Contraceptives, Oral; Decision Making; Dipyridamole; Drug Combinations; Drug Evaluation; Evidence-Based Medicine; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Information Dissemination; Pharmacoepidemiology; Phenylpropanolamine; Review Literature as Topic; Risk Assessment; Stroke; Tissue Plasminogen Activator

2007
Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:1-2

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Data Interpretation, Statistical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Telmisartan; Ticlopidine

2008
Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
    The Journal of the Oklahoma State Medical Association, 2008, Volume: 101, Issue:5

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke

2008
Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:2

    Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Female; Humans; Stevens-Johnson Syndrome

2009
[Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
    MMW Fortschritte der Medizin, 2009, Jul-23, Volume: 151, Issue:30-33

    Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Practice Guidelines as Topic; Secondary Prevention

2009
A multi-case report of acute renal failure in patients treated with Aggrenox.
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2010,Summer, Volume: 17, Issue:2

    Topics: Acute Kidney Injury; Aspirin; Aspirin, Dipyridamole Drug Combination; Creatinine; Dipyridamole; Drug Combinations; Humans

2010
Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention.
    International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:6

    Topics: Aged; Algorithms; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Confidence Intervals; Dipyridamole; Drug Combinations; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Research Design; Sample Size; Stroke; Tissue Plasminogen Activator; Treatment Outcome

2011
Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine

2013
Spray drying as a fast and simple technique for the preparation of extended release dipyridamole (DYP) microparticles in a fixed dose combination (FDC) product with aspirin.
    Drug research, 2014, Volume: 64, Issue:2

    Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Microscopy, Electron, Scanning; Particle Size; Solubility; Technology, Pharmaceutical; X-Ray Diffraction

2014
Syncope during a pharmacologic nuclear stress test.
    Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:5

    Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug Interactions; Exercise Test; Female; Heart Arrest; Humans; Middle Aged; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Syncope

2014
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
    Journal of endourology, 2015, Volume: 29, Issue:11

    Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment

2015
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
    Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult

2019